The Pharmacist

SEPTEMBER 11, 2024

Slow progress on the community pharmacy prescribing pathfinder project has sparked concerns that a viable commissioned community pharmacy prescribing service will not be ready by 2026, The Pharmacist has learned.

Community Pharmacies 105

Community Pharmacies 105

PharmaVoice

OCTOBER 23, 2024

As Sanofi prepares to halt production on its dengue vaccine in 2026, locally acquired infections in the U.S. are raising the alarm.

Vaccines 246

Vaccines 246

Express Pharma

APRIL 8, 2025

Steris Healthcare, a pharmaceutical company headquartered in Mumbai with operations in Navi Mumbai, has unveiled a 50 crore growth strategy aimed at expanding its manufacturing capacity, entering new regional markets, and launching an Initial Public Offering (IPO) in FY 202627.

Pharmaceutical Companies 66

Pharmaceutical Companies Pharmaceutical Companies 66

STAT

AUGUST 13, 2024

In a press release, the company said that the cuts would help it extend its cash reserves from the second half of 2026 into 2028. The Bay Area biotech brought in $32 million during the quarter but also reported a net loss of $1.6 Continue to STAT+ to read the full story…

355

355

pharmaphorum

OCTOBER 24, 2024

Denmark's Lundbeck has said that efforts to build its R&D portfolio are on track to deliver four new molecular entities (NMEs) in phase 3 trials in 2026, including an epilepsy drug from its recently announced $2.6 billion takeover of Longboard Pharma.

105

105

The Pharmacist

NOVEMBER 26, 2024

Pharmacists have been urged to continue to promote the importance of folic acid supplementations following news that it will be added to non-wholemeal flour from the end of 2026.

116

116

STAT

OCTOBER 9, 2024

The Congressional Budget Office estimates that 29 million beneficiaries would qualify for weight loss drugs in 2026.    Drugs for those conditions already exist, and they’re often generic. But a lot of people are switching to GLP-1s.   Continue to STAT+ to read the full story…

Diabetes 329

Diabetes 329

European Pharmaceutical Review

SEPTEMBER 12, 2023

Over 50 percent of respondents answered that machine learning for optimisation of manufacturing processes will be the technology that will be used routinely in the pharmaceutical industry by 2026. The post AI to revolutionise drug development by 2026 appeared first on European Pharmaceutical Review.

Drug Development 105

Drug Development Pharmaceutical Companies Pharmaceutical Companies 105

STAT

SEPTEMBER 23, 2024

Though the DEA is currently contemplating new regulations that would roll back many of the pandemic-era flexibilities, the lawmakers’ new bill would likely extend the current rules through 2026, according to two lobbyists familiar with the effort.  

Controlled Substances 323

Controlled Substances 323

STAT

SEPTEMBER 20, 2024

The new guidance will affect nearly 6,000 universities and other institutions with projects funded by HHS, which have until 2026 to comply.

334

334

Express Pharma

SEPTEMBER 23, 2024

Gupta has been elected as the National President of the Indian Pharmaceutical Association (IPA) for the term 2024-2026. Dr Gupta’s term will run from October 1, 2024 to 30th September 2026. gupta elected National President of Indian Pharmaceutical Association for 2024-2026 term appeared first on Express Pharma. The post Dr R.

Community Pharmacies 105

Community Pharmacies Hospitals 105

STAT

APRIL 16, 2024

It would carve grocers, restaurants, and food warehouses out of a major portion of the FDA’s rules, which are meant to help regulators quickly track down the cause of a foodborne outbreak, and it would delay enforcement of the entire food safety program, slated to begin in 2026, by several years.

349

349

STAT

FEBRUARY 14, 2025

trillion between 2026 and 2035. There is a lot of pressure to make big cuts to government spending. The Treasury Department estimates that renewing the expiring individual and estate tax provisions would cost $4.2 A group of nine Senate Republicans, including Majority Leader John Thune (S.D.)

329

329

STAT

JUNE 18, 2024

Freespira CEO Joe Perekupka told STAT the company believes it will break even by the end of 2025 and will become cash flow positive in 2026. Perekupka said Freespira hopes to enroll 2,500 people in its treatment this year — twice last year’s sales — and to double its patients again in 2025 and 2026.

258

258

STAT

FEBRUARY 1, 2024

  The negotiated prices won’t take effect until 2026.  The Biden administration will publish the final prices by Sept. 1 of this year after the negotiation process ends.    Continue to STAT+ to read the full story…

Drug Pricing 312

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies 312

European Pharmaceutical Review

AUGUST 19, 2022

billion by 2026. percent between 2021 and 2026 (the forecast period). Billion by 2026, achieving a 5.6 billion by 2026, as contract manufacturing organisations increasingly adopt newer and efficient ways to package products, increasing demand for new machinery. billion by the year 2026. Within the $130.2

Packaging 98

Packaging Compounding 98

STAT

SEPTEMBER 4, 2024

The sites are expected to employ another 90 people and open by 2026.  The pharmaceutical giant will spend more than $200 million to construct the new facility in Carlsbad, Calif., and expand its site in Indianapolis, representatives told STAT exclusively.

Drug Development 290

Drug Development 290

STAT

JUNE 24, 2024

But that deal, though eventually closed, was scuttled by regulatory issues in both the U.S. and Europe, and European regulators forced Illumina to spin Grail back out. Grail now says it expects to file for full approval in the U.S. In the meantime, the company is running an annual loss of about $500 million a year.

312

312

Express Pharma

APRIL 2, 2024

GS Krishnan, President of Association of Biotechnology Led Enterprises (ABLE) has been re-elected for another two-year term from April 2024 – 2026. The post GS Krishnan re-elected ABLE President for 2024 -2026 appeared first on Express Pharma.

105

105

STAT

SEPTEMBER 8, 2023

The negotiation, informed by confidential data from manufacturers and analysis by the Centers for Medicare and Medicaid Services, will result in a maximum fair price for each drug, which will be announced Sept. 1, 2024, and will take effect Jan. The Congressional Budget Office has estimated that the negotiations could save Medicare about $3.7

Drug Pricing 308

Drug Pricing 308

STAT

SEPTEMBER 12, 2023

The cuts extend the company’s cash runway into 2026. It also plans to allocate less money to a couple of drug candidates, including one that is currently on hold with the Food and Drug Administration. The company was formed in 2021 when the team behind Bluebird Bio decided to split its drug pipeline down the middle.

339

339

STAT

OCTOBER 31, 2023

As Medicare prepares to negotiate prices for its first batch of medicines, an advocacy group argues the agency should factor in controversial patent maneuvers for one drug that will have cost the program nearly $2 billion in additional spending by 2026.

Drug Pricing 316

Drug Pricing 316

STAT

JUNE 11, 2024

Lightpath Metabolic, expected to be available in 2026, will not only include programs for people with type 1 and type 2 diabetes and hypertension — as the current iteration of Onduo does — but will also offer GLP-1 drug prescriptions.

Diabetes 308

Diabetes 308

STAT

OCTOBER 3, 2022

1, 2026, opening up JAMA’s or Nature’s website, and being able to read any article for free. Most people who heard the news likely envisioned making a cup of coffee on Jan. Read the rest…

246

246

PharmaVoice

MARCH 11, 2025

Emalex Biosciences is full steam ahead with a targeted 2026 approval and launch for its novel drug.

179

179

STAT

OCTOBER 8, 2024

The latest effort involves tripling the annual supply of the drug, a long-acting medication known as cabotegravir, in hopes of making more than 2 million doses available during 2025 and 2026.

Drug Pricing 285

Drug Pricing 285

STAT

AUGUST 30, 2023

Department of Health and Human Services named 10 medicines that will be subject to price negotiations for the Medicare program in 2026, a milestone and a point to start appraising the impact of the law , STAT explains. Have a wonderful day, and please do stay in touch. … On Tuesday, the U.S. The landscape here is complicated.

Biosimilars 258

Biosimilars Drug Pricing 258

STAT

OCTOBER 11, 2023

The decision meant that data from roughly half of the trial were scrapped, which delayed their plans to seek regulatory approval for the shot until 2026, instead of 2025. Pfizer and Valneva maintained there were no safety issues or adverse events prompting the decision, and instead blamed unspecified problems with the conduct of the study.

Vaccines 275

Vaccines 275

Express Pharma

DECEMBER 26, 2024

The site and product dossier approvals are expected to be received by the end of 2026. As part of this initiative, Akums Group will initiate the European approval process for its oral liquid manufacturing facility, leveraging this approval to produce the contracted products.

105

105

National Association of Boards of Pharmacy

APRIL 16, 2025

Uniform MPJE Launches Spring 2026 Although the content outline will be released soon, the uniform version of the MPJE is expected to launch in June 2026. The content outline for this new exam will be released in May 2025. The development process will remain responsive to the evolving needs of the pharmacy community.

76

76

STAT

MAY 20, 2024

Even assuming that all of these hospitals voluntarily report their greenhouse gas emissions, they constitute a trivial amount of one of the world’s largest sources of such emissions, making up nearly 9% of total annual U.S. greenhouse gas emissions and 4.5% of the total worldwide , along with an equal amount of toxic air pollutants.

Hospitals 264

Hospitals Inpatient 264

PharmaVoice

AUGUST 16, 2024

The final negotiations slash drug prices between 38% and 79% for Medicare’s 2026 calendar year.

Drug Pricing 147

Drug Pricing 147

STAT

AUGUST 16, 2024

billion ) in 2026. Well, there’s CMS’ estimate for how much would have been saved by the Medicare program had the MFPs been in effect in 2023 ( $6 billion ), and the estimate for how much seniors will save out-of-pocket just from the lower prices ( $1.5

Drug Pricing 275

Drug Pricing Diabetes 275

STAT

OCTOBER 20, 2022

Moreover, the process does not start until 2026. But those medicines can’t have any competing products on the market, and negotiations can’t begin until a small-molecule drug has been available for at least nine years and a biologic for 13 years.

Drug Pricing 246

Drug Pricing 246

The Pharmacist

JANUARY 16, 2025

The commissioners […] The post PCNs will continue into 2026, NHS England confirms appeared first on The Pharmacist. Speaking in a webinar for GPs on last week (9 January), NHS England said: The future of PCNs is secure for 25/26 with additional funding being implemented through ARRS [the Additional Roles Reimbursement Scheme].

59

59

Commonwealth Pharmacists Association

APRIL 2, 2025

of the programme, which will run until March 2026, […] The Commonwealth Pharmacists Association (CPA) and Global Health Partnerships are delighted to announce the extension of our Commonwealth Partnerships for Antimicrobial Stewardship programme (CwPAMS).

72

72

PharmaVoice

NOVEMBER 5, 2024

Rallybio is headed into a mid-stage trial with enough cash through 2026, but the cyclical market has made the journey difficult.

130

130